A MULTI-CENTER, OPEN-LABEL, EXPLORATORY STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN SUBJECTS ≥1 MONTH TO <18 YEARS WITH EPILEPSY SYNDROMES ASSOCIATED WITH GENERALIZED SEIZURES.

SP0966 is an exploratory study to investigate safety and efficacy of Lacosamide (LCM) in children with epilepsy syndromes associated with generalized seizures. LCM will be added to current antiepileptic treatment.

SP0966是一项探索性研究，旨在探讨拉考沙胺（Lacosamide, LCM）在伴全面性发作的癫痫综合征儿童患者中的安全性与有效性，研究将在受试者当前的抗癫痫治疗基础上加用拉考沙胺。